A Study to Evaluate the Consistency of Oscillometry and Spirometry Test Results in Patients With Confirmed or Suspected Asthma or COPD

CompletedOBSERVATIONAL
Enrollment

801

Participants

Timeline

Start Date

February 8, 2024

Primary Completion Date

August 30, 2024

Study Completion Date

August 30, 2024

Conditions
Asthma/ COPD
Interventions
DIAGNOSTIC_TEST

suspected asthma

enrollment 200 asthma patients

DIAGNOSTIC_TEST

suspected COPD

enrollment 200 COPD patients

DIAGNOSTIC_TEST

confirmed asthma

enrollment 200 patients

DIAGNOSTIC_TEST

confirmed COPD

enrollment 200 patients

Trial Locations (41)

Unknown

Research Site, Beijing

Research Site, Changsha

Research Site, Chengdu

Research Site, Chongqing

Research Site, Dalian

Research Site, Fengcheng

Research Site, Fuyang

Research Site, Fuzhou

Research Site, Guangzhou

Research Site, Guiyang

Research Site, Haikou

Research Site, Hanchuan

Research Site, Hangzhou

Research Site, Haozhou

Research Site, Henan

Research Site, Hong Kong

Research Site, Jinan

Research Site, Jingzhou

Research Site, Kunming

Research Site, Mianyang

Research Site, Nanchang

Research Site, Nantong

Research Site, Ningbo

Research Site, Ordos

Research Site, Panzhou

Research Site, Qionghai

Research Site, Shanghai

Research Site, Shenyang

Research Site, Shenzhen

Research Site, Suining

Research Site, Suzhou

Research Site, Taiyuan

Research Site, Taizhou

Research Site, Tianjin

Research Site, Xinyang

Research Site, Yulin

Research Site, Yunnan

Research Site, Zhaotong

Research Site, Zhengzhou

Research Site, Zhuji

Research Site, Zigong

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY